Android
Zerodha Broker (Free Delivery)

India's No. 1 Broker with Best Software Trade @ Flat Rs 20

Open Instant Account
market update arrow Vehicle scrapping rules allow single window clearance for setting up ATSes arrow Coronavirus LIVE: India records 29,616 fresh cases, active cases rise arrow PM Modi raises issue of H-1B visas during first-ever meeting with Joe Biden arrow 'Pak has history of supporting terrorists', India slams Imran Khan at UNGA arrow Huawei CFO leaves Canada after agreement with US over fraud charges arrow PM Narendra Modi reaches New York to address 76th UNGA session arrow Tesla starts judging owners it charged $10,000 for self-driving arrow China's top regulators ban crypto trading, sending bitcoin tumbling arrow France, Germany nominate WHO chief Tedros for a second term arrow Govt will mandate flex-fuel engines in vehicles in next 3-4 months: Gadkari arrow RBI permits lenders to sell fraud loans to ARCs, paves way for resolution arrow Five stocks drive Sensex from 50,000 to 60,000: Check details here arrow Structural bull-run in Indian stock market remains intact: Chris Wood arrow Indian economy on sustained path of revival: Finance Minister Sitharaman arrow Advance tax collection up 52% in September quarter, shows CBDT data arrow Global oil and gas investment will be 30% below pre-Covid level: ONGC arrow Aditya Birla AMC eyes Rs 20,500 cr valuation in Rs 2,768 cr IPO arrow Daikin to set up Rs 1,000-crore AC manufacturing plant in Andhra Pradesh arrow Daikin to set up Rs 1,000-crore AC manufacturing plant in Andhra Pradesh arrow Shilpa Medicare to make drug substance for Cadila's ZyCoV-D vaccine arrow Sensex sprints to 60,000: Latest 5,000-pt rally comes in record 28 sessions arrow Birlas fail to nominate directors on the board of MP Birla group companies

BIOCON LTD.360.15 -8.05 (-2.19%)

  • BSE: 532523
  • |
  • NSE: BIOCON
  • |
  • ISIN NO: INE376G01013
  • |
  • INDUSTRY: Biotechnology
Price table
Date Open High Low Close Volume Delivery % 20-Day SMA 50-Day SMA 200-Day SMA
24-Sep-2021 368.50 369.85 358.00 360.15 1493295 36.80 360.50 372.05 401.20
23-Sep-2021 369.00 371.80 366.55 368.20 1257724 27.29 359.55 372.60 401.55
22-Sep-2021 365.20 368.50 363.25 367.55 2107108 41.96 358.50 373.00 401.85
21-Sep-2021 364.00 369.15 356.00 367.25 2727117 17.22 357.60 373.40 402.20
20-Sep-2021 376.00 376.00 359.00 360.40 3169722 28.15 355.90 373.85 402.50
17-Sep-2021 390.00 394.15 370.15 377.40 18497586 25.32 355.75 374.50 402.85
16-Sep-2021 357.50 379.00 355.85 376.75 5530580 24.80 355.35 374.70 403.05
Key Data
  • Market cap 45233.00 CR.
  • Book value 65.90
  • Stock P/E 192
  • Dividend Yield 0.00%
  • ROCE 4.60%
  • ROE 3.59%
  • Sales Growth (3Y) 0.00%
  • Face Value (3Y) 5.00
BIOCON Share Price:

BIOCON share is currently trading at 360.15 at the PE of 192.

The 52-week range of BIOCON share price is 327.55 ~ 487.75

BIOCON share has a current face value of ₹5.00/-

Profile

BIOCON

Biocon Limited or BIOCON

Biocon, which is Asia's largest biotechnology company, started itself with a seed capital of INR 10, 000 in the year 1978, and currently, it is a billion dollar company. It also manufactures the biotechnological products catering to the healthcare section and engages itself in all the phases of the product cycle from discovering to development & then commercializing the same drugs. It consists of a fermentation-based technology which is creating cost ... -effective, and some of its subsidiaries are Syngene and Clinigene for the international pharmaceutical and biotechnology majors. Biocon produces antidiabetic agents like Acarbose, Pioglitazone, and Repaglinide & Rosiglitazone. In the biological section, it produces Insulin, Erythropoietin (EPO), Filgrastim (GCSF), and Streptokinase & Monoclonal Antibodies. The drug major provides mycophenolate mofetil, tacrolimus, and sirolimus. It also produces and market mix of specialty & industrial enzymes for industries such as brewing, paper, beverages, food, brewing, textiles & distilling. The company's drug portfolio also consists of lovastatin, simvastatin, pravastatin, and atorvastatin.

The Business of the Company:

It has a fully integrated business model that spans the entire drug value chain, from the preclinical discovery to clinical development and through to commercialization. Its businesses are spread in various custom research (Syngene), clinical development (Clinigene) and biopharmaceuticals (Biocon) which provides multiple revenue streams to balance risk, drive innovation, deliver products, and accelerates the growth. As the company has increased both the complexity as well as the scope of its R&D and manufacturing operations, especially in the case of new product discovery and development, it is believed that the custom, as well as clinical research services, will continue to offer such essential synergies.

 

 

 

 

 

 

The Milestones:

 

 

 

Some Awards:

 

 

 

 

 

 

 

 

Read More
Trend Analysis
  • Short Term Trend :
    Down
  • Medium Term Trend :
    Not Clear
  • Long Term Trend :
    Not Clear

Are you friends with trend?

There is a saying in stock market, "Trend is your best friend"

It means, a good trader doesn't place his money against the trend. Many new traders lose money because they are trying to catch trend reversals but seasoned traders wait for a clear trend to emerge before taking the trade in the direction of trend.

Day Technicals

What is Opening Range Breakout?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

NR7

What is NR7 trading strategy?

Narrow Range trading strategy or NR7 Trading strategy is a breakout based method which assumes that the price of security trends up or down after a brief consolidation in a narrow range.

Opening Price clues

How to use Opening Price Clues in your trades?

If the stock has same open and high after it has traded for some time, it implies there was a consistent selling pressure that didn't allow the stock to move higher from the opening price. Similarly, if the stock has same open and low price, it implies there was a consistent buying intent that kept the stock price above the opening price.

Day High Low Range
TIME LOWEST HIGHEST
10 AM - -
11 AM - -
12 PM - -
1 PM - -
2 PM - -
Japanese Candlestick Patterns
Candle Pattern 1 :None
Candle Pattern 2 : None
Candle Pattern 3 :None
Candlestick Price Action
Lower High Lower Low
Pivot Points
Name S4 S3 S2 S1 Pivot Points R1 R2 R3 R4
classic 353.10 358.35 363.60 365.90 368.85 371.15 374.10 379.35 384.60
woodie's 355.88 361.13 363.84 366.38 369.09 371.62 374.34 376.88 382.12
fibonacci - 363.60 365.60 366.84 368.85 370.86 372.10 374.10 -
camarilla 365.31 366.76 367.24 367.72 -- 368.68 369.16 369.64 371.09
Past Performance & Moving Averages
Day’s LOW HIGH RANGE SMA Stock PERFORMANCE Nifty PERFORMANCE
10 DAY
350.05
394.15
364.45 4.31 % 2.63 %
20 DAY
339.55
394.15
360.50 2.26 % 2.75 %
50 DAY
327.55
414.40
372.05 -3.54 % 9.95 %
100 DAY
327.55
420.25
382.46 -8.52 % 13.21 %
200 DAY
327.55
487.75
401.19 -5.90 % 19.46 %
YTD
327.55
474.35
395.08 -20.54 % 27.39 %
52 Week
327.55
487.75
406.87 -16.41 % 25.31 %

Why are moving Averages important in technical Analysis?

An opening range breakout is breaking out of the day's range after a stock has moved for some time in a sideways trend. In technical terms, its a breakout from the support and resistance level in an upward or downward trend.

Gaps On Day Chart
Unfilled Gap Down On 2021-01-22
423.00 ~ 440.15 RESISTANCE
Unfilled Gap Up On 2020-04-07
297.30 ~ 295.85 SUPPORT
Unfilled Gap Down On 2019-06-12
271.35 ~ 525.50 RESISTANCE
Unfilled Gap Down On 2017-06-15
346.00 ~ 1014.00 RESISTANCE
Industry Growth Rate

In Last 1 Year the industry has grown by 15.68 %

In Last 5 Year the industry has grown by 12.78 %

Peer comparison

Sales

COMPANY NAME 2015 2016 2017 2018 2019 2020
BIOCON 3090.00 3347.00 3891.00 4123.00 5514.00 6367.00
PANACEABIO 687.00 653.00 544.00 593.00 457.00 544.00
ALPA 57.25 53.46 63.45 62.13 76.96 85.37
Total 3834.25 4053.46 4498.45 4778.13 6047.96 6996.37

Financial

LAST FISCAL CURRENT GROWTH 10 YEAR CAGR
S.NO. COMPANY NAME MARKET CAP CMP BOOK VALUE EPS STOCK P/E ROE ICR REVENUE NET PROFIT NPM REVENUE NET PROFIT REVENUE NET PROFIT
1 PANACEA BIOTEC LTD. 175939.50 286.25 58.36 -31.69 0.00 -32.33 0.31% 544.00 -194.00 -35.66% 19.04% -610.53% -4.91% NaN
2 BIOCON LTD. 43224.00 360.20 60.95 6.24 47.32 1.25 24.22% 6367.00 748.00 11.75% 15.47% -17.35% 10.40% 9.83%
3 ALPA LABORATORIES LTD. 3892.69 18.50 51.66 0.88 23.24 0.09 28.15% 85.37 1.85 2.17% 10.93% 134.18% 0.00% 0.00%
Sales

What is Sales Trend ?

Sales trend is a methodology to understand sales results which helps in understanding the trends of the market over a specific period of time. Sales results are an indicative of the sales patterns followed by the customer over a time period.

Profitability
Net Profit
EPS

What is EBITDA Margin & EBIT Margin ?

Corporate accounting is required to adhere to the standards and practices collectively referred to as the generally accepted accounting principles. EBITDA is an excellent way for corporate accountants to start compiling data, but it should not be considered an absolute result. This is due to the fact that many consider EBITDA more of a broad stroke than a definitive form of accounting practice.

EBITDA Margin
EBIT Margin
NPM
Cash Flow

Why is the Cash Flow Analysis important?

A business needs cash to pay its expenses, to pay bank loans, to pay taxes and to purchase new assets. A cash flow report determines whether a business has enough cash to do exactly this.

Operating Activities
Financing Activities
Investing Activities
Financial Health

What Is Financial Health?

Financial health is a term used to describe the state of one's personal monetary affairs. There are many dimensions to financial health, including the amount of savings you have, how much you’re putting away for retirement, and how much of your income you are spending on fixed or non-discretionary expenses.

Debt to Equity
Piotroski Score
  • 0
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

What Is the Piotroski Score?

The Piotroski score is a discrete score between 0-9 that reflects nine criteria used to determine the strength of a firm's financial position.

Altman Z Score (Mfg Company)
  • Distress (< 1.81)
  • Caution (>1.81 < 2.99)
  • 4.65
    Safe (3 & above)
Altman Z Score (Non-Mfg Company)
  • Distress ( < 1.23)
  • Caution (>1.23 < 2.6)
  • 8.74
    Safe (2.6 & above)
Valuation

What Is Valuation?

Valuation is the analytical process of determining the current (or projected) worth of an asset or a company. There are many techniques used for doing a valuation. An analyst placing a value on a company looks at the business's management, the composition of its capital structure, the prospect of future earnings, and the market value of its assets, among other metrics.

BIOCON: Future
TRADING SYMBOL OI VOLUME LAST PRICE LOT SIZE EXPIRY DATE
BIOCON21SEPFUT 15626200.00 3604100.00 359.50 2300.0 2021-09-30
BIOCON21OCTFUT 4301000.00 2355200.00 361.00 2300.0 2021-10-28
BIOCON21NOVFUT 209300.00 62100.00 363.50 2300.0 2021-11-25
ROLLOVER COST: 0.42% (INR 1.50)
ROLLOVER%:22.40%
What is the significance of Rollover data?

Rollover in an important data point and should be analyzed in the expiry week. Rollover involves carry forwarding of ‘futures’ positions from one series (which is nearing expiry date) to the next one.

Rollover percentage actually indicates whether the traders are willing to carry forward their existing. positions (long or short) to the next series or not. Generally, the rollover figures alone will not indicate which direction traders are betting on. You should also check whether absolute open interest is increasing or decreasing over expiries

What is Options Max Pain Theory?

Options Max Pain Theory suggests,

“On option expiration day, the underlying stock price often moves toward a point that brings maximum loss to option buyers.”

Bulk Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
BIOCON 2007-10-09 JF ASSET MANAGEMENT LIMITED S 650000.00 483.28
BIOCON 2006-01-27 FIDILITY FID FUND P 1351807.00 470.00
BIOCON 2006-01-27 GLENTEC INTERNATIONAL S 2298800.00 470.00
BIOCON 2005-12-28 GLENTEC INTERNATIONAL S 1432403.00 491.85
BIOCON 2005-12-28 THE MASTER TRUST BANKER J P 680250.00 491.85
BIOCON 2005-03-30 ANIL KUMAR AGARWAL P 31822.00 403.75
BIOCON 2005-03-30 ANUBHAV AGARWAL S 31822.00 403.75
BIOCON 2004-04-13 AOF HS Mauritius Ltd. S 2000000.00 608.53
BIOCON 2004-04-13 AOF HS Mauritius Ltd. S 2830000.00 605.70
BIOCON 2004-04-13 Emerging Markets MGT.LLC/ P 367060.00 605.00
BIOCON 2004-04-13 Emerging Markets MGT.LLC/ P 383440.00 605.00
BIOCON 2004-04-13 Goldman Sachs Invst. Maur P 386560.00 605.00
BIOCON 2004-04-13 Goldman Sachs Invst. Maur P 3080000.00 605.00
BIOCON 2004-04-13 HSBC Equity Fund P 300000.00 605.00
BIOCON 2004-04-13 HSBC India Opportunities P 150000.00 605.00
BIOCON 2004-04-13 Mahesh Kumar Damani P 367062.00 666.68
BIOCON 2004-04-13 Mahesh Kumar Damani S 367062.00 658.85
Block Deals
Symbol Name Deal Date Client Name Transcation Type Quantity Price
BIOCON 2020-08-05 BOFA SECURITIES EUROPE SA P 272822.00 413.80
BIOCON 2020-08-05 MERRILL LYNCH MARKETS SINGAPORE PTE LTD S 272822.00 413.80
BIOCON 2016-02-23 NEW INDIA INVESTMENT TRUST PLC P 240000.00 471.35
BIOCON 2016-02-23 NEW INDIA INVESTMENT COMPANY MAURITIUS LIMITED S 240000.00 471.35
Dividend history
Bonus Data
Company Name Split Date From Value To Value
BIOCON LTD. 2019-06-12 1.00 1.00
BIOCON LTD. 2017-06-15 2.00 1.00
BIOCON LTD. 2008-09-11 1.00 1.00
Split Data
Company Name Split Date From Value To Value
No Data Found.